Medical Advocates
HCV Infection/Disease
  Special Populations

 General Reports                      Mentally Ill
Pregnant Women/Neonates    Veterans
Children                                  Older Persons
 Healthcare Workers                Misc Populations
African-Americans     
 Latinos/Latinas 
Dialysis Patients
Hemophiliacs
Substance Users; General
IDUs
MSM
Incarcerated
HCV Main Page Main New/Newsworthy   Home Page    
Last Update:  July 10, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 

          Journal Papers, Abstracts, and Commentaries

 
Anti-HCV positivity in sexual partners and offspring of patient with chronic hepatitis C.
 Aykın N, Cevık F, Demırturk N, 
Scand J Infect Dis. 2008;40(6):533-537.
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
 Treatment of chronic HCV infection in special populations.
 Hoefs J, Aulakh VS.
nt J Med Sci. 2006;3(2):69-74.
 Paper
 
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
 Backus LI, Boothroyd D, Deyton LR.  
AIDS. 2005 Oct;19 Suppl 3:S13-9.
 Abstract

Treatment of hepatitis C in special populations.
 Moylan CA, Muir AJ. 
Clin Liver Dis. 2005 Nov;9(4):567-77.
 Abstract
African-Americans
 

General Reports

          Journal Papers, Abstracts, and Commentaries

 
Hepatitis C Hypervariable Region 1: Association of Reduced Selection Pressure in African
Americans with Treatment Failure.
 Park VM, Mason BC, Krushkal J, et al
Dig Dis Sci. 2007 Apr 5;
Abstract
 
Hepatitis C in African Americans.
Pyrsopoulos N, Jeffers L
J Clin Gastroenterol. 2007 Feb;41(2):185-193.
Abstract
 
Hepatitis C virus infection in African Americans.
 Pearlman BL.
Clin Infect Dis. 2006 Jan 1;42(1):82-91.
 Abstract
 
Management of hepatitis C virus in special populations: Patient and treatment considerations.
Gish RG, Afdhal NH, Dieterich DT, Reddy KR.
Clin Gastroenterol Hepatol. 2005 Apr;3(4):311-8
 Abstract

Chronic hepatitis C in African Americans and other minority groups.
Fleckenstein J. 
Curr Gastroenterol Rep. 2004 Feb;6(1):66-70.
 Abstract

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and
non-Hispanic whites.
Muir AJ, Bornstein JD, Killenberg PG, et al
N Engl J Med. 2004 May 27;350(22):2265-71.
 Abstract
 
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans
with severe mental illness.
Butterfield MI, Bosworth HB, Stechuchak KM, et al 
J Natl Med Assoc. 2004 Jan;96(1):43-52
 Abstract
 
Comparison of 125I-interferon-alpha binding to peripheral blood cells from African-Americans
and Caucasians with hepatitis C.
Kimball P, Verbeke S, Shiffman M.
J Viral Hepat. 2003 Sep;10(5):354-9.
 Abstract
 
Relationship between transferrin saturation and iron stores in the African American and
US Caucasian populations: analysis of data from the third National Health and Nutrition
Examination Survey.
McLaren CE, Li KT, Gordeuk VR, et al
Blood. 2001 Oct 15;98(8):2345-5
 Abstract

Epidemiology/Incidence/Natural History

          Journal Papers, Abstracts, and Commentaries

 
Hepatitis C and its risk management among drug injectors in London: renewing harm
reduction in the context of uncertainty.
 Rhodes T, Davis M, Judd A.
Addiction. 2004 May;99(5):621-33.
 Abstract

Hepatitis C infection in African Americans: its natural history and histological progression.
Wiley TE, Brown J, Chan J.
Am J Gastroenterol. 2002 Mar;97(3):700-6
 Abstract

Treatment

     General Reports

           Journal Papers, Abstracts, and Commentaries

  Treatment of Chronic Hepatitis C Virus in African Americans With Genotypes 2 and 3.
 Shiffman ML, Mihas AA, Millwala F, et al 
Am J Gastroenterol. 2007 Feb 22
 Abstract

      Interferon- alpha 2b

            Journal Papers, Abstracts, and Commentaries

 
Hepatitis C and its risk management among drug injectors in London: renewing harm reduction
in the context of uncertainty.
 Rhodes T, Davis M, Judd A.
Addiction. 2004 May;99(5):621-33.
 Abstract

Intensive interferon therapy does not increase virological response rates in African Americans with
chronic hepatitis C.
Theodore D, Shiffman ML, Sterling RK, et al
Dig Dis Sci. 2003 Jan;48(1):140-5.
Abstract
 
African Americans with genotype 1 treated with interferon for chronic hepatitis C have
a lower end of treatment response than Caucasians.
Kinzie JL, Naylor PH, Nathani MG, t al
J Viral Hepat. 2001 Jul;8(4):264-9.
Abstract

      Interferon- alpha 2b/Ribivirin

            Journal Papers, Abstracts, and Commentaries

  Viral dynamics and response differences in HCV-infected African American and white patients
treated with IFN and ribavirin.
Layden-Almer JE, Ribeiro RM, Wiley T,
Hepatology. 2003 Jun;37(6):1343-50.
 Abstract
Latinos/Latinas
         

           Journal Papers, Abstracts, and Commentaries

  Chronic hepatitis C in latinos: natural history, treatment eligibility, acceptance, and outcomes.
 Cheung RC, Currie S, Shen H, al 
Am J Gastroenterol. 2005 Oct;100(10):2186-93.
 Abstract
Healthcare Workers
         
  Blood-Borne Pathogens; General
Hepatitis C
Hemophiliacs
 

          Journal Papers, Abstracts, and Commentaries

 
Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in
persons with haemophilia.
 Angelotta C, McKoy JM, Fisher MJ, et al 
Vox Sang. 2007 Aug;93(2):159-65.
 Abstract
 
FULL-TEXT ARTICLE
 High efficacy of combined therapy with pegylated interferon plus ribavirin in patients
with hemophilia and chronic hepatitis C.
 Mancuso ME, Rumi MG, Santagostino E, et al 
Haematologica. 2006 Oct;91(10):1367-71.
 Paper
 
Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.
Posthouwer D, Mauser-Bunschoten EP. et al
Haemophilia. 2006 Sep;12(5):473-8.
Abstract
 
Treatment of hepatitis C in hemophiliacs.
Franchini M, Nicolini N, Capra F.
 Am J Hematol. 2006 Sep;81(9):696-702.
Abstract

Hepatitis C at the Israeli national hemophilia center.
Maor Y, Bashari D, Kenet G, et al
 Haemophilia. 2006 Jan;12(1):68-74.
Abstract
 
Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in
hemodialysis patients.
 Bouzgarrou N, Fodha I, Othman SB, et al 
J Med Virol. 2005 Oct 27;77(4):502-508
Abstract
 
Hepatitis C and health-related quality of life among patients with hemophilia.
 Posthouwer D, Plug I, van der Bom JG, et al 
Haematologica. 2005 Jun;90(6):846-50
 Abstract
 
Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR.
 Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH. 
Intervirology. 2005 Jul-Aug;48(4):213-5
 Abstract

Hepatitis C in haemophilia: lights and shadows.
 Rumi MG, De Filippi F, Santagostino E, Colombo M. 
Haemophilia. 2004 Oct;10 Suppl 4:211-5
 Abstract
 
  Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult
hemophilic patients.
 Santagostino E, De Filippi F, Rumi MG,  
 Transfusion. 2004 May;44(5):790-4
 Abstract
 
  Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders
and hepatitis C infection.
 DiMichele DM, Mirani G, Wilfredo Canchis P, et al
Haemophilia. 2003 Sep;9(5):613-618.
 Abstract
 
  Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were
nonresponders to a previous interferon treatment.
 Franchini M, Rossetti G, Capra F, et al.
Haemophilia 2002 Nov;8(6):794-797
 Abstract
 
  Update on chronic hepatitis C in hemophiliacs.
 Franchini M, Capra F, Tagliaferri A
 Haematologica 2002 May;87(5):542-9
 Abstract
 
  The natural history and antiviral treatment of hepatitis C in haemophilia.
 Lee C, Dusheiko G.
Haemophilia 2002 May;8(3):322-9
 Abstract
Dialysis Patients
 

     Journal Papers, Abstracts, and Commentaries
 
Hepatitis C in Dialysed Patients - What Is the Current Optimal Treatment?
 Kes P, Basic-Jukic N.   
 Kidney Blood Press Res. 2007 Apr 20;30(3):156-161
 Abstract
 
FULL TEXT ARTICLE
Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the
Southwest Parana State, Brazil.
 Engel M, Malta FM, Gomes MM 
BMC Public Health. 2007 Apr 4;7:50.
Paper
 
Effects of Adding Ribavirin to Interferon to Treat Chronic Hepatitis C Infection: A Systematic
Review and Meta-analysis of Randomized Trials.
 Brok J, Gluud LL, Gluud C. 
Arch Intern Med. 2005 Oct 24;165(19):2206-12.
Abstract
 
Efficacy of Interferon-alpha in the Treatment of Chronic Hepatitis C in Dialysis Patients: Two Therapeutic
Protocols Compared.
 Grgurevic I, Vince A, Buljevac M, et al 
Nephron Clin Pract. 2005 Dec 21;103(1):c8-c11
Abstract
 
Risk factors for hepatitis C virus infection in patients on long-term hemodialysis.
 Khokhar N, Alam AY, Naz F, Mahmud SN.
 J Coll Physicians Surg Pak. 2005 Jun;15(6):326-8.
 Abstract
 
Transmission of hepatitis C virus between hemodialysis patients sharing the same machine.
 Sartor C, Brunet P, Simon S, et al 
Infect Control Hosp Epidemiol. 2004 Jul;25(7):609-11.
 Abstract
 
FULL-TEXT ARTICLE
 Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with
4-23 years of follow-up.
 Okuda K, Yokosuka O.
World J Gastroenterol. 2004 Aug 1;10(15):2209-12
 Paper
 
Treatment of Early Diagnosed HCV Infection in Hemodialyzed Patients with Interferon-alpha.
Treatment of Hepatitis C.
 Urbanek P, Tesar V, Prochazkova-Francisci E, et al
Blood Purif. 2004 Jul 16;22(4):344-350.
 Abstract

Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the
hemodialysis machine?
Delarocque-Astagneau E, Baffoy N
 Infect Control Hosp Epidemiol 2002 Jun;23(6):328-34
 Abstract

High prevalence of hepatitis C infection among patients receiving hemodialysis at an
urban dialysis center.
Sivapalasingam S, Malak SF, Sullivan JF, et al.
Infect Control Hosp Epidemiol 2002 Jun;23(6):319-24
 Abstract

Dialysis-Membrane-Dependent Reduction and Adsorption of Circulating Hepatitis C Virus
during Hemodialysis.
Mizuno M, Higuchi T, Yanai M, et al
Nephron 2002 Jun;91(2):235-42
 Abstract

L-carnitine administration reverses acute mental status changes in a chronic hemodialysis 
patient with hepatitis C infection.
DaVanzo WJ, Ullian ME.
Clin Nephrol 2002 May;57(5):402-5
 Abstract

Significance of parenteral iron administration for HCV-positive hemodialysis patients
 Kurihara I, Saito T.
 Nippon Jinzo Gakkai Shi 2002 May;44(4):389-95
 Abstract

Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus
infection and non-hemodialysis patients with hepatitis cirrhosis.
 Ng YY, Lin CC, Wu SC, Hwang SJ, et al.
 Clin Nephrol 2002 Apr;57(4):289-95
Abstract

 
Substance Users: General Reports
IDUs
          Journal Papers, Abstracts, and Commentaries
 
 
Homelessness, drug use and Hepatitis C: A complex problem explored within the context of
social exclusion.
 Neale J.
Int J Drug Policy. 2007 Oct 23;
 Abstract
 
Management of hepatitis C among drug user patients.
 Moussalli J, Melin P, Wartelle-Bladou C, Lang JP.
Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 3):51-5.
 Abstract
 
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.
 Grebely J, Raffa JD, Lai C, et al
Can J Gastroenterol. 2007 Jul;21(7):447-51.
 Abstract
 
Treatment for hepatitis C virus and cannabis use in illicit drug user patients: implications and
questions
 Fischer B, Reimer J, Firestone M, et al 
Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1039-42.
 Abstract
 
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.
 Sylvestre DL, Clements BJ, Malibu Y.
Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1057-63
 Abstract

Psychiatric and Substance Use Disorders in Individuals with Hepatitis C : Epidemiology and
Management.
 Loftis JM, Matthews AM, Hauser P
 Drugs. 2006;66(2):155-174
 Abstract
Veterans
United States
United States  
   
          Journal Papers, Abstracts, and Commentaries
 
 
Management of Chronic Hepatitis C in Veterans: The Potential of Integrated Care Models.
 Ho SB, Groessl E, Dollarhide A, et al 
Am J Gastroenterol. 2008 Jun 16
 Abstract
 
Racial Differences in the Evaluation and Treatment of Hepatitis C Among Veterans:
A Retrospective Cohort Study.
 Rousseau CM, Ioannou GN, Todd-Stenberg JA, et al
 Abstract
 
Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
 Backus LI, Boothroyd DB, Phillips BR, Mole LA.
 Hepatology. 2007 Jul;46(1):37-47.
 Abstract
 
Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage,
treatment received, and survival.
 Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP.
Clin Gastroenterol Hepatol. 2007 Apr;5(4):508-12.
 Abstract
 
Management of Hepatitis C Disease Among VA Patients With Schizophrenia and
Substance Use Disorders.
 Huckans MS, Blackwell AD, Harms TA, Hauser P. 
Psychiatr Serv. 2006 Mar;57(3):403-6.
 Abstract
 
Survival in hepatitis C and HIV co-infection: A cohort study of hospitalized veterans.
 El-Serag HB, Giordano TP, Kramer J, et al   
Clin Gastroenterol Hepatol. 2005 Feb;3(2):175-83
 Abstract
 
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S.
veterans with hepatitis C.
 Kramer JR, Giordano TP, Souchek J, et al 
Am J Gastroenterol. 2005 Jan;100(1):56-63.
 Abstract
 
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.
Dominitz JA, Boyko EJ, Koepsell TD, et al
Hepatology. 2004 Dec 23;41(1):88-96 [
 Abstract
 
Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a
US veteran population.
 Piasecki BA, Lewis JD, Reddy KR, et al 
Hepatology. 2004 Sep 20;40(4):892.
 Abstract
 
Combination therapy for the treatment of hepatitis C in the veteran population: higher than
expected rates of therapy discontinuation.
 Getachew Y, Browning JD, Prebis M, et al
 Aliment Pharmacol Ther. 2004 Sep 15;20(6):629-36.
Abstract
 
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans
with severe mental illness.
 Butterfield MI, Bosworth HB, Stechuchak KM, et al 
J Natl Med Assoc. 2004 Jan;96(1):43-52
 Abstract

Prevalence of Hepatitis C virus infection in a sample of homeless veterans.
 Desai RA, Rosenheck RA, Agnello V.
Soc Psychiatry Psychiatr Epidemiol. 2003 Jul;38(7):396-401
Abstract
Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans
with human immunodeficiency virus infection.
 Fultz SL, Justice AC, Butt AA, et al.  
Clin Infect Dis 2003 Apr 15;36(8):1039-46
Abstract
Psychiatric disorders among veterans with hepatitis C infection.
 el-Serag HB, Kunik M, Richardson P, Rabeneck L.
Gastroenterology 2002 Aug;123(2):476-82
Abstract
Spectrum of disease in U.S. veteran patients with hepatitis C.
 Nguyen HA, Miller AI, Dieperink E, et al.
Am J Gastroenterol 2002 Jul;97(7):1813-20
 Abstract
 
Mentally Ill
 

     Journal Papers, Abstracts, and Commentaries

 
Hepatitis C Services and Individuals with Serious Mental Illness.
 Goldberg RW, Seth P
Community Ment Health J. 2008 May 9
Abstract
 
Comparison of hepatitis C treatment patterns in patients with and without psychiatric
and/or substance use disorders
 Chainuvati S, Khalid SK, Kancir S, et al 
J Viral Hepat. 2006 Apr;13(4):235-41.
 Abstract
 
Psychiatric and Substance Use Disorders in Individuals with Hepatitis C : Epidemiology and
Management.
 Loftis JM, Matthews AM, Hauser P
Drugs. 2006;66(2):155-174
 Abstract
 
Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use
disorders.
 Rosenberg SD, Drake RE, Brunette MF, et al 
AIDS. 2005 Oct;19 Suppl 3:S26-33.
Abstract
 
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans
with severe mental illness.
 Butterfield MI, Bosworth HB, Stechuchak KM, et al 
J Natl Med Assoc. 2004 Jan;96(1):43-52.
Abstract

Adherence and mental side effects during hepatitis C treatment with interferon alfa and
ribavirin in psychiatric risk groups.
 Schaefer M, Schmidt F, Folwaczny C, et al.
Hepatology 2003 Feb;37(2):443-51
 Abstract

Prevalence of hepatitis C among psychiatric patients in the public sector.
 Dinwidie SH, Shicker L, Newman T.
Am J Psychiatry 2003 Jan;160(1):172-4
 Abstract
 
Older Persons
 

          Journal Papers, Abstracts, and Commentaries

 
Treatment Eligibility and Outcomes in Elderly Patients with Chronic Hepatitis C: Results
from the VA HCV-001 Study.
 Tsui JI, Currie S, Shen H, et al 
Dig Dis Sci. 2007 Sep 1;
 Abstract

Hepatitis C in 6,865 Patients 65 yr or Older: A Severe and Neglected Curable Disease?
Thabut D, Le Calvez S, Thibault V, et al
Am J Gastroenterol. 2006 Jun;101(6):1260-7.
 Abstract
Miscellaneous Populations
 

     Journal Papers, Abstracts, and Commentaries

 
Homelessness, drug use and Hepatitis C: A complex problem explored within the context of
social exclusion.
 Neale J.
Int J Drug Policy. 2007 Oct 23;
Abstract
 
Hepatitis C Infection Is Associated with Lower Lipids and High-Sensitivity C-Reactive Protein in
HIV-Infected Men.
 Floris-Moore M, Howard AA, et al 
AIDS Patient Care STDS. 2007 Jul;21(7):479-91.
 Abstract
 
Limitation of combination therapy of interferon and ribavirin for older patients with chronic
hepatitis C.
Iwasaki Y, Ikeda H, Araki Y, et al 
Hepatology. 2006 Jan;43(1):54-63.